Increased matrix metalloproteinase-9 in blood in association with activation of interleukin-6 after traumatic brain injury: Influence of hypothermic therapy

Journal of Neurotrauma

Volumn 21, Issue 12, 2004, Pages 1706-1711

  Suehiro, Eiichi ^a   Fujisawa, Hirosuke ^a   Akimura, Tatsuo ^a   Ishihara, Hideyuki ^a   Kajiwara, Koji ^a   Kato, Shoichi ^a   Fujii, Masami ^a   Yamashita, Susumu ^a   Maekawa, Tsuyoshi ^a   Suzuki, Michiyasu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood brain barrier; Hypothermia; Interleukin 6; Matrix metalloproteinase 9; Traumatic brain injury

Indexed keywords

GELATINASE B;

ADOLESCENT; ADULT; AGED; ARTERIAL BLOOD; ARTICLE; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BRAIN INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; ENZYME RELEASE; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPOTHERMIA; HYPOTHERMIC THERAPY; INFLAMMATION; JUGULAR VEIN; MALE; NEUROPROTECTION; VENOUS BLOOD;

ADOLESCENT; ADULT; AGED; ARTERIES; BRAIN INJURIES; FEMALE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HUMANS; HYPOTHERMIA, INDUCED; INTERLEUKIN-6; JUGULAR VEINS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; TIME FACTORS;

EID: 9744230671     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2004.21.1706     Document Type: Article

References (25)

1. AIBIKI, M., MAEKAWA, S., OGURA, S., et al. (1999). Effect of moderate hypothermia on systemic and internal jugular plasma IL-6 levels after traumatic brain injury in humans. J. Neurotrauma 16, 225-232.
2. BARZO, P., MARMAROU, A., FATOUROS, P., CORWIN, F., and DUNBER, J. (1996). Magnetic resonance imaging-monitored acute blood-brain barrier changes in experimental traumatic brain injury. J. Neurosurg. 85, 1113-1121.
3. ENGEL, S., SCHLUESENER, H., MITTELBRONN, M., et al. (2000). Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14. Acta Neuropathol. 100, 313-322.
4. GASCHE, Y., FUJIMURA, Y., COPIN, J., et al. (1999). Early appearance of activated MMP-9 after focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19, 1020-1028.
5. GOTTSCHALL, P.E., and YU, X. (1995). Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J. Neurochem. 54, 1513-1520.
6. GOTTSCHALL, P.E., YU, X., and BING, B. (1995). Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. J. Neurosci. Res. 42, 335-342.
7. HARKNESS, K.A., ADAMSON, P., SUSSMAN, J.D., DAVIES-JONES, G.A.B., GREENWOOD, J., and WOODROOFE, M.N. (2000). Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain 123, 698-709.
8. LIU, J., FARMER, J.D., LANE, Jr., W.S., FRIEDMAN, J., WEISSMAN, I., and SCHREIBER, S.L. (1991). Calcineurin is a common target of cyclophilin cyclosporin A and FKBP FK506 complex. Cell 66, 807-815.
9. McCLAIN, C., COHEN, D., PHILLIPS, R., OTT, L., and YOUNG, B. (1991). Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J. Lab. Clin. Med. 118, 225-231.
10. MINAMBRES, E., CEMBORAIN, A., SANCHEZ-VELASCO, P., GANDARILLAS, M., DIAZ-REGANON, G., SANCHEZ-GONZALEZ, U., and LEYVA-COBIAN, F. (2003). Correlation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury. Crit. Care Med. 31, 933-938.
11. MORI, T., WANG, X., JUNG, J., et al. (2002). Mitogen activated protein kinase inhibition for traumatic brain injury: in vitro and in vivo effects. J. Cereb. Blood Flow Metab. 22, 444-452.
12. MORITA-FUJIMURA, Y., FUJIMURA, M., GASCHE, Y., et al. (1999). Overexpression of copper and zinc Superoxide dismutase in transgenic mice prevents the induction and activation of matrix metalloproteinases after cold injury induced brain trauma. J. Cereb. Blood Flow Metab. 20, 130-138.
13. MUN-BRYCE, S., and ROSENBERG, G.A. (1998). Matrix metalloproteinases in cerebrovascular disease. J. Cereb. Blood Flow Metab. 18, 1163-1172.
14. OKONKWO, D.O., and POVLISHOCK, J.T. (1999). An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury. J. Cereb. Blood Flow Metab. 19, 443-451.
15. PETTY, M.A., and LO, E.H. (2002). Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog. Neurobiol. 68, 311-323.
16. RAO, A., LUO, C., and HOGAN, P.G. (1997). Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15, 707-747.
17. ROSENBERG, G.A., NAVRATIL, M., BARONE, F., et al. (1996). Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J. Cereb. Blood Flow Metab. 16, 360-366.
18. ROSENBERG, G.A., and NAVARATIL, M. (1997). Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 48, 921-926.
19. ROSENBERG, G.A., CUNNINGHAM, L.A., WALLACE, J., et al. (2001). Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res. 893, 104-112.
20. SCHUMANN, G., HUELL, M., MACHEIN, U., HOCKE, G., and FIEBICH, B.L. (1999). Interleukin-6 activates signal transducer and activator of transcription and mitogen-activated protein kinase signal transduction pathways and induces de novo protein synthesis in human neuronal cells. J. Neurochem. 73, 2009-2017.
21. SINGLETON, R.H., STONE, J.R., OKONKWO, D.O., PELLICANE, A.J., and POVLISHOCK, J.T. (2001). The immunophilin ligand FK506 attenuates axonal injury in an impact-acceleration model of traumatic brain injury. J. Neurotrauma 18, 607-614.
22. WANG, X., JUNG, J., ASAHI, M., et al. (2000). Effects of matrix metalloproteinase 9 gene knockout on morphological and motor outcomes after traumatic brain injury. J. Neurosci. 20, 7037-7043.
23. YAMAMOTO, T., MORI, K., and MAEDA, M. (2002). Assessment of prognostic factors in severe traumatic brain injury patients treated by mild therapeutic cerebral hypothermia therapy. Neurol. Res. 24, 789-795.
24. ZAWADZKA, M., and KAMINSKA, B. (2003). Immunosuppressant FK 506 affects multiple signaling pathways and modulates gene expression in astrocytes. Mol. Cell. Neurosci. 22, 202-209.
25. ZHANG, Z.G., ZHANG, L., TSANG, W., et al. (2001). Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion. Brain Res. 912, 181-194.